- Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity2023 | Second Faculty of Medicine
- Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry2018 | Second Faculty of Medicine
- Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS2024 | Second Faculty of Medicine
- Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: A large patient cohort study2017 | Second Faculty of Medicine
- Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib2017 | Second Faculty of Medicine
- Genetic defects in PI3K delta affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections2017 | Second Faculty of Medicine
- Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome2014 | Second Faculty of Medicine
- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | Second Faculty of Medicine, First Faculty of Medicine
- CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID2019 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové